326 related articles for article (PubMed ID: 18815107)
21. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
[TBL] [Abstract][Full Text] [Related]
22. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
Dolder M; Tutuian R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
[TBL] [Abstract][Full Text] [Related]
23. [How to choose correct proton pump inhibitors to patients with GERD?].
Bordin DS
Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811
[TBL] [Abstract][Full Text] [Related]
24. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
25. [In patients with typical symptoms of GERD and without alarm symptoms, what are the most appropriate dose and duration of empirical PPI therapy that would allow a definitive diagnosis of GERD?].
Ponce M
Gastroenterol Hepatol; 2009 Feb; 32(2):126-7. PubMed ID: 19231690
[No Abstract] [Full Text] [Related]
26. The proton pump inhibitor (PPI) test in GERD: does it still have a role?
Gasiorowska A; Fass R
J Clin Gastroenterol; 2008 Sep; 42(8):867-74. PubMed ID: 18645525
[TBL] [Abstract][Full Text] [Related]
27. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
28. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
[TBL] [Abstract][Full Text] [Related]
29. Refractory GERD: what is it?
Fass R; Gasiorowska A
Curr Gastroenterol Rep; 2008 Jun; 10(3):252-7. PubMed ID: 18625135
[TBL] [Abstract][Full Text] [Related]
30. Optimal management of severe symptomatic gastroesophageal reflux disease.
Talley NJ; Zand Irani M
J Intern Med; 2021 Feb; 289(2):162-178. PubMed ID: 32691466
[TBL] [Abstract][Full Text] [Related]
31. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
[TBL] [Abstract][Full Text] [Related]
33. Refractory gastroesophageal reflux disease.
Moraes-Filho JP
Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
[TBL] [Abstract][Full Text] [Related]
34. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
35. [Noncardiac chest pain and gastroesophageal reflux disease].
Dimache M; Turcan E; Nătase M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
[TBL] [Abstract][Full Text] [Related]
36. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitor use in infants: FDA reviewer experience.
Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
[TBL] [Abstract][Full Text] [Related]
38. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Yadlapati R; DeLay K
Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
Isshi K; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Ogawa M; Arihiro S; Haruma K; Nakada K
J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of gastroesophageal reflux disease (GERD)].
Storr M
Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
